Across
- 2. This 1987 study showed that enalapril decreased the progression of severe HF and mortality from it.
- 4. This 2001 study showed that losartan reduced the risk of developing ESRD in patients with diabetes
- 6. This 1991 study showed that enalapril was superior to hydralazine+isosorbide in terms of mortality reduction in HF patients.
- 7. This 2008 study showed that benazepril plus amlodipine was more effective than benazepril plus HCTZ at reducing cardiovascular events in high risk patients with HTN.
- 9. This 2014 study showed that valsartan-sacubitril reduced the risk of hospitalizations and death from HF
- 11. This 1999 study showed that metoprolol reduced mortality in patients with symptomatic HF.
- 12. This 2001 study showed that a LV assist device reduced all-cause mortality in patients in severe heart failure on optimal GDMT
- 15. This 2011 study showed that the dosage of loop diuretics had no significant effect on overall effectiveness or safety in acute decompensated HF.
- 17. This 1994 study showed that ivabradine reduced hospitalization and death from HF in patients with a baseline heart rate > 70.
- 18. This 1999 study showed that spironolactone reduced all-cause mortality in patients with LVEF <=35%
- 19. This 2009 study showed that cardiac resynchronization therapy, in addition to ICDs, reduced the risk of HF events in patients with HFrEF and prolonged QRS>130ms.
- 21. This 2015 study showed that an SBP target of 120 was superior to 140 in high-risk patients with HTN without DM.
Down
- 1. This 2010 study showed that intense BP control did not reduce rates of MI, stroke, CV mortality in patients with diabetes
- 3. This 2005 study showed that ICDs decreased mortality in patients with LVEF <=35% and NYHA II-III symptoms
- 5. This was the first randomized controlled trial of hypertension treatment anywhere in the world.
- 8. This 1997 study showed that a combination diet rich in fruits and vegetables and low in fat reduced blood pressure in comparison to the typical American diet.
- 10. This 2000 study demonstrated ramipril reducing CV events in high-risk patients without HFrEF
- 13. This 2002 study showed that the addition of carvedilol to standard severe heart failure (EF<25%) therapy resulted in significant mortal risk reduction.
- 14. This 2002 study established thiazides as the first-line therapy for hypertension
- 16. This 1999 study showed that high-dose ACE inhibitors reduced hospitalizations or death from HF compared to a lower dose.
- 20. This 1998 study showed that DBP goal of 80mmHg did not further reduce CV events than a DBP goal of 90.
